EUVIMEDEUVIMED entdecken
Open Access

Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis

Laura M Mafla iD, Raymond J So iD, Ibrahim Abd-Elazem, Samuel L Collins, Yee Chan-Li iD, Gabriela Lilly, Ioan A Lina iD, Alexander H Gelbard iD, Alexander T Hillel iD, Kevin M Motz iD

The Laryngoscope · 2025

DOI: 10.1002/lary.31934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Laura M Mafla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. Hauptthemen laut MEDLINE: Laryngostenosis, Calgranulin B, Calgranulin A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS, NHLBI NIH HHS, National Institute on Deafness and Other Communication Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Idiopathic subglottic stenosis (iSGS) is a progressive fibrotic condition of the subglottis that presents in women of northern European descent. Endoscopic dilation is a common surgical approach to management of iSGS. The surgery‐free interval, or the time between endoscopic dilation procedures is considered an indicator of disease severity. Variations in surgery‐free intervals among iSGS patients underscore the necessity for prognostic biomarkers. The objective of this study was to explore serum levels of the damage‐associated molecular pattern S100A8/A9 as a prognostic biomarker in iSGS.

Methods

Serum from 20 iSGS patients and eight healthy controls was collected and S100A8/A9 levels were quantified using an ELISA. Patient data, including demographics and surgery‐free intervals, were obtained from medical records. Serum S100A8/A9 levels were compared to surgery‐free intervals. S100A8/A9 was also assessed using gene expression and immunofluorescence in iSGS specimens.

Results

S100A8/A9 was significantly elevated ( p = 0.0413) in the serum of iSGS patients compared to controls (312.75 vs. 181.49 ng/mL). Linear regression analysis revealed a correlation ( p = 0.009) between S100A8/A9 levels and endoscopic surgery‐free interval. S100A8/A9 was significantly elevated ( p = 0.0011) in patients with surgery‐free intervals less than 1 year (455.2 ± 60.45 ng/mL; n = 8) compared to patients with intervals over 1 year (292.5.93 ± 162.4; n = 6).

Conclusion

S100A8/A9 is increased in the serum and tissue of patients with iSGS. In this cohort of iSGS patients, serum S100A8/A9 was associated with surgery‐free intervals, potentially representing a prognostic biomarker. Further research within a larger cohort is needed to confirm these findings. Level of Evidence 3 Laryngoscope , 135:1724–1731, 2025

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaryngostenosisCalgranulin BCalgranulin AHumansFemaleMaleMiddle AgedBiomarkersAdultPrognosisCase-Control StudiesAged

Stichwörter der Autor:innen

S100A8/A9idiopathic subglottic stenosislaryngotracheal stenosissurgery‐free interval

Substanzen

Calgranulin BCalgranulin ABiomarkersS100A9 protein, humanS100A8 protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.
  • Department of Otolaryngology Head and Neck Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A.

ORCID-Profile: Laura M Mafla, Raymond J So, Yee Chan-Li, Ioan A Lina, Alexander H Gelbard, Alexander T Hillel, Kevin M Motz

Förderung

  • NIDCD NIH HHS
  • NHLBI NIH HHS
  • National Institute on Deafness and Other Communication Disorders
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Mafla, L. M., So, R. J., Abd-Elazem, I., Collins, S. L., Chan-Li, Y., Lilly, G., Lina, I. A., Gelbard, A. H., Hillel, A. T., & Motz, K. M. (2025). Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis. The Laryngoscope. https://doi.org/10.1002/lary.31934

Vancouver

Mafla LM, So RJ, Abd-Elazem I, Collins SL, Chan-Li Y, Lilly G, et al. Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis. The Laryngoscope. 2025. doi:10.1002/lary.31934

BibTeX
@article{Mafla2025,
  author = {Mafla, Laura M and So, Raymond J and Abd-Elazem, Ibrahim and Collins, Samuel L and Chan-Li, Yee and Lilly, Gabriela and Lina, Ioan A and Gelbard, Alexander H and Hillel, Alexander T and Motz, Kevin M},
  title = {Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis},
  journal = {The Laryngoscope},
  year = {2025},
  doi = {10.1002/lary.31934}
}
Kostenlos starten →